Novel pretargeted radionuclide therapy for HER2-expressing cancers shows promise

by Society of Nuclear Medicine and Molecular ImagingTransversal (A), coronal (B), sagittal (C) nanoSPECT/CT images and maximum intensity projection (D) obtained 30 h after injection of pretargeted&nbs

Updated on: March 06,2024

Novel pretargeted radionuclide therapy for HER2-expressing cancers shows promise

by Society of Nuclear Medicine and Molecular ImagingTransversal (A), coronal (B), sagittal (C) nanoSPECT/CT images and maximum intensity projection (D) obtained 30 h after injection of pretargeted&nbs

Updated on:March 06,2024

Researchers create new tool for assessing risk of kidney injury after chemotherapy

by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainUsing patient data from six major U.S. cancer centers, Brigham researchers and collaborators developed a risk prediction model for

Updated on: March 30,2024

Researchers create new tool for assessing risk of kidney injury after chemotherapy

by Brigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainUsing patient data from six major U.S. cancer centers, Brigham researchers and collaborators developed a risk prediction model for

Updated on:March 30,2024

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im

Updated on: January 02,2024

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im

Updated on:January 02,2024

New marker could detect fatal breast cancer up to one year earlier than current methods

by BioMed CentralMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA new marker that could be used to diagnose fatal breast cancer up to one year ah

Updated on: March 01,2024

New marker could detect fatal breast cancer up to one year earlier than current methods

by BioMed CentralMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA new marker that could be used to diagnose fatal breast cancer up to one year ah

Updated on:March 01,2024

Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

by Dana-Farber Cancer InstituteCredit: CC0 Public DomainResearchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors—known as pNETs—that have dramatically different risks

Updated on: May 13,2024

Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

by Dana-Farber Cancer InstituteCredit: CC0 Public DomainResearchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors—known as pNETs—that have dramatically different risks

Updated on:May 13,2024

The blind use of AI in health care can lead to invisible discrimination

by University of CopenhagenCredit: CC0 Public DomainArtificial intelligence can help health care systems under pressure allocate limited resources, but also lead to more unequal access. This is d

Updated on: April 22,2024

The blind use of AI in health care can lead to invisible discrimination

by University of CopenhagenCredit: CC0 Public DomainArtificial intelligence can help health care systems under pressure allocate limited resources, but also lead to more unequal access. This is d

Updated on:April 22,2024

AI effective in diagnosis of head and neck cancer, finds researcher

by Claes Björnberg,Umea UniversityCredit: Pixabay/CC0 Public DomainStudies in a new doctoral thesis indicate that an AI-supported method is effective in the diagnosis of squamous cell carcinoma

Updated on: February 01,2024

AI effective in diagnosis of head and neck cancer, finds researcher

by Claes Björnberg,Umea UniversityCredit: Pixabay/CC0 Public DomainStudies in a new doctoral thesis indicate that an AI-supported method is effective in the diagnosis of squamous cell carcinoma

Updated on:February 01,2024

Study may explain why once-promising cancer drugs failed

by Duke UniversityInvading cells (green) in the lab wormC. elegans(purple) can change their tactics to get around cancer drugs called MMP inhibitors and trespass into other tissues. T

Updated on: May 21,2024

Study may explain why once-promising cancer drugs failed

by Duke UniversityInvading cells (green) in the lab wormC. elegans(purple) can change their tactics to get around cancer drugs called MMP inhibitors and trespass into other tissues. T

Updated on:May 21,2024

Effect of religiosity/spirituality on ovarian cancer diagnosis in African American women

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAn examination of data from a multi-center case-control study of ovarian cancer in African American women found that women who re

Updated on: April 01,2024

Effect of religiosity/spirituality on ovarian cancer diagnosis in African American women

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAn examination of data from a multi-center case-control study of ovarian cancer in African American women found that women who re

Updated on:April 01,2024

Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

by Elana GotkineInsurance status mediates racial and ethnic inequities in advanced-stage cervical cancer diagnosis, according to a study published online March 10 inJAMA Network Open.Hunter K. H

Updated on: January 23,2024

Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

by Elana GotkineInsurance status mediates racial and ethnic inequities in advanced-stage cervical cancer diagnosis, according to a study published online March 10 inJAMA Network Open.Hunter K. H

Updated on:January 23,2024

Study reports blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

byLouisiana State UniversityCredit:Frontiers in ImmunologyDOI: 10.3389/fimmu.2022.987298A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strateg

Updated on: January 16,2024

Study reports blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

byLouisiana State UniversityCredit:Frontiers in ImmunologyDOI: 10.3389/fimmu.2022.987298A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strateg

Updated on:January 16,2024

Placebo pill eases cancer-related fatigue in study

by Alan MozesPatients with advanced cancer often suffer crippling fatigue, but there has been little in the way of relief for them as they battle their disease.Now, a new investigation may have landed

Updated on: March 06,2024

Placebo pill eases cancer-related fatigue in study

by Alan MozesPatients with advanced cancer often suffer crippling fatigue, but there has been little in the way of relief for them as they battle their disease.Now, a new investigation may have landed

Updated on:March 06,2024